Additionally, the therapeutic efficiency in vitro and the applicability of two PSMA-targeting model radioconjugates on LNCaP tumor-bearing mice were shown in a proof of concept study on these triazole-containing click conjugates. The gene discussed is FOLH1; the disease is neoplasm.